JPH07164604A - Base material for medicare container - Google Patents
Base material for medicare containerInfo
- Publication number
- JPH07164604A JPH07164604A JP5279461A JP27946193A JPH07164604A JP H07164604 A JPH07164604 A JP H07164604A JP 5279461 A JP5279461 A JP 5279461A JP 27946193 A JP27946193 A JP 27946193A JP H07164604 A JPH07164604 A JP H07164604A
- Authority
- JP
- Japan
- Prior art keywords
- layer
- polypropylene
- polymer
- container
- sheet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 title abstract description 9
- 229920000642 polymer Polymers 0.000 claims abstract description 39
- -1 polypropylene Polymers 0.000 claims abstract description 38
- 239000004743 Polypropylene Substances 0.000 claims abstract description 34
- 229920001155 polypropylene Polymers 0.000 claims abstract description 33
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 229920001684 low density polyethylene Polymers 0.000 claims abstract description 12
- 239000004702 low-density polyethylene Substances 0.000 claims abstract description 12
- 229920006125 amorphous polymer Polymers 0.000 claims abstract description 6
- 229920001083 polybutene Polymers 0.000 claims abstract description 5
- 229920001577 copolymer Polymers 0.000 claims description 5
- 238000007789 sealing Methods 0.000 abstract description 18
- 229920005606 polypropylene copolymer Polymers 0.000 abstract 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 6
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 5
- 239000000306 component Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 229920000098 polyolefin Polymers 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 229920000092 linear low density polyethylene Polymers 0.000 description 3
- 239000004707 linear low-density polyethylene Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920001748 polybutylene Polymers 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 239000004711 α-olefin Substances 0.000 description 2
- AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 1
- CRSBERNSMYQZNG-UHFFFAOYSA-N 1-dodecene Chemical compound CCCCCCCCCCC=C CRSBERNSMYQZNG-UHFFFAOYSA-N 0.000 description 1
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 description 1
- 241001456553 Chanodichthys dabryi Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical group COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical group CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 239000002998 adhesive polymer Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004031 devitrification Methods 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical group O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920006124 polyolefin elastomer Polymers 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000003856 thermoforming Methods 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Laminated Bodies (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は血液、医薬液等医療分野
において扱われる液体を保存する容器、搬送するチュー
ブ(連結管)等に適した医療容器用基材に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a base material for a medical container, which is suitable for a container for storing liquids such as blood and medical liquids used in the medical field, a tube for transporting (connecting pipe) and the like.
【0002】[0002]
【従来の技術】採血、輸血、輸液等の医療分野において
用いられる容器やチューブの材料には安全性・衛生性の
他種々の性能が要求され、なかでも柔軟性、透明性、耐
熱性及びこれらのバランスは重視される項目である。2. Description of the Related Art Materials for containers and tubes used in the medical field such as blood sampling, blood transfusion, and liquid transfusion are required to have various performances in addition to safety and hygiene. Among them, flexibility, transparency, heat resistance and The balance of is an important item.
【0003】上記用途のポリマー素材としては従来から
軟質ポリ塩化ビニル及びエチレン−酢酸ビニルコポリマ
ー、低密度ポリエチレンの如きポリエチレン系ポリマー
が代表例であるが、軟質ポリ塩化ビニルでは可塑剤の溶
出、着色、廃棄処理などにおいて問題を生じることがあ
る。As a polymer material for the above-mentioned use, polyethylene-based polymers such as soft polyvinyl chloride, ethylene-vinyl acetate copolymer, and low-density polyethylene have hitherto been representative examples. In soft polyvinyl chloride, elution and coloring of a plasticizer, May cause problems in disposal.
【0004】ポリエチレン系の場合は柔軟性、透明性と
耐熱性とのバランスに欠け、低密度品は柔軟性、透明性
が比較的よいが必然的に軟化点が低くなるので耐熱性が
低下し、通常100〜130℃で行われる高圧蒸気滅菌
に耐えられず、ブロッキング、失透(白化)、アバタ状
のムラの発生、変形などを生じやすい。耐熱性を上げる
方法として化学架橋、放射線架橋等があるが、製造工程
の複雑化は免れ得ない。In the case of polyethylene, the balance between flexibility, transparency and heat resistance is lacking, and low density products have relatively good flexibility and transparency, but the softening point is inevitably low, resulting in a decrease in heat resistance. However, it cannot withstand high-pressure steam sterilization usually performed at 100 to 130 ° C., and is likely to cause blocking, devitrification (whitening), avatar-like unevenness, and deformation. Chemical crosslinking, radiation crosslinking and the like are available as methods for increasing heat resistance, but the manufacturing process is inevitably complicated.
【0005】また、結晶性ポリプロピレンも医療用容器
に広く使われているポリマーであり、その良好な耐熱性
はポリエチレンに比してはるかに有利であるが、高剛性
であり(柔軟性に乏しい)、また融点が高いため熱シー
ルしにくく、製袋性に難がある。結晶性ポリプロピレン
を柔軟化するにはスチレン系エラストマーやアモルファ
スポリプロピレン(アタクチックポリプロピレン)をブ
レンドするのが良いとされ、特にアモルファスポリプロ
ピレンと結晶性ポリプロピレンとのブレンド物からなる
層を結晶性ポリプロピレンの層で挟んだサンドウィッチ
型構造の多層体(多層シート)は該ブレンド物の粘着性
(ブロッキング性)を抑えつつ柔軟なシートを得る手段
として有効である(例えば特開平5−77371号に提
案されている)。Crystalline polypropylene is also a polymer that is widely used in medical containers, and although its good heat resistance is far more advantageous than polyethylene, it has high rigidity (poor flexibility). Moreover, since the melting point is high, it is difficult to perform heat sealing, and the bag-making property is difficult. It is said that blending styrene elastomer or amorphous polypropylene (atactic polypropylene) is a good way to soften crystalline polypropylene. The sandwiched sandwich type multilayer body (multilayer sheet) is effective as a means for obtaining a flexible sheet while suppressing the tackiness (blocking property) of the blend (proposed in, for example, JP-A-5-77371). .
【0006】しかしながら、このような構造ではやはり
結晶性ポリプロピレンがシール層を形成し、かつ、柔軟
で流動しやすいブレンド物を中間層に持つため熱シール
しにくい問題はさらに顕著である。However, in such a structure, since the crystalline polypropylene still forms the sealing layer and the soft and fluid blend is contained in the intermediate layer, the problem of difficulty in heat sealing becomes more remarkable.
【0007】[0007]
【発明が解決しようとする課題】本発明者らは従来技術
の持つ上述の如き諸問題が解決された医療容器用基材を
提供すべく、アモルファスポリオレフィン適用の多層体
におけるシール性改良に焦点をあてて検討した。DISCLOSURE OF THE INVENTION In order to provide a substrate for medical containers in which the above-mentioned problems of the prior art are solved, the present inventors have focused on improving the sealing property in a multilayer body to which amorphous polyolefin is applied. I examined it.
【0008】[0008]
【課題を解決するための手段】本発明の要旨は、結晶性
ポリプロピレン又はこれを主成分とする結晶性コポリマ
ーからなる層(A)、ポリプロピレン系もしくはポリブ
テン系アモルファスポリマーを重合体組成物として含有
する層(B)及び低密度ポリエチレンからなる層(C)
によって形成された多層体であって、(A)、(B)及
び(C)がそれぞれ最外層、中間層及び最内層に存在す
ることを特徴とする医療容器用基材であり、このような
構成とすることによって、透明性、柔軟性及び耐熱性が
維持されつつシール性の優れた医療容器用基材となる。The gist of the present invention is to include a layer (A) made of crystalline polypropylene or a crystalline copolymer containing the crystalline polypropylene as a main component, and a polypropylene-based or polybutene-based amorphous polymer as a polymer composition. Layer (B) and layer consisting of low density polyethylene (C)
And (A), (B) and (C) are present in the outermost layer, the intermediate layer and the innermost layer, respectively. By adopting the constitution, it becomes a medical container base material excellent in sealing property while maintaining transparency, flexibility and heat resistance.
【0009】即ち、最内層(容器の内壁層)は高圧蒸気
滅菌時に直接蒸気に触れないので比較的耐熱性の低いポ
リエチレンであっても滅菌に耐えることができ、最外層
(容器の外壁層)のポリプロピレンの耐熱性、中間層の
アモルファスポリオレフィン含有層の透明性、柔軟性に
よって、透明性、柔軟性及び耐熱性のバランスに優れ、
しかも低密度ポリエチレンがシール層であるので良好な
加工性を持つ基材となるのである。That is, since the innermost layer (inner wall layer of the container) does not come into direct contact with steam during high-pressure steam sterilization, even polyethylene having relatively low heat resistance can withstand sterilization, and the outermost layer (outer wall layer of the container). Due to the heat resistance of polypropylene, the transparency and flexibility of the amorphous polyolefin-containing layer of the intermediate layer, the balance of transparency, flexibility and heat resistance is excellent,
Moreover, since the low-density polyethylene is the sealing layer, it becomes a base material having good processability.
【0010】本発明において(A)を構成する結晶性ポ
リプロピレン又はこれを主成分とする結晶性コポリマー
(以下、ポリプロピレン系結晶性ポリマーと称す)は通
常の立体規則性構造のポリプロピレン即ちアイソタクチ
ックもしくはシンジオタクチックタイプのポリマーであ
る。In the present invention, the crystalline polypropylene constituting (A) or a crystalline copolymer containing the crystalline polypropylene as a main component (hereinafter referred to as a polypropylene-based crystalline polymer) is a polypropylene having an ordinary stereoregular structure, that is, isotactic or It is a syndiotactic type polymer.
【0011】これらは適宜選択されるが、透明性や柔軟
性という点でコポリマー特にランダムコポリマーが有利
である。コモノマーとしてはエチレン、ブテン−1、ペ
ンテン−1、ヘキセン−1、オクテン−1、デセン−
1、ドデセン−1、4−メチルペンテン−1など炭素原
子数2〜12のα−オレフィン量が良く、コモノマー量
3〜40モル%程度、より好ましくは5〜30モル%程
度が適当である。Although these are appropriately selected, copolymers, particularly random copolymers, are advantageous in terms of transparency and flexibility. As the comonomer, ethylene, butene-1, pentene-1, hexene-1, octene-1, decene-
The amount of α-olefin having 2 to 12 carbon atoms such as 1, dodecene-1, 4-methylpentene-1 is good, and the amount of comonomer is preferably about 3 to 40 mol%, more preferably about 5 to 30 mol%.
【0012】特に好ましいポリプロピレン系結晶性ポリ
マーは曲げ弾性率(JISK7203)が9,000k
g/cm2 以下でビカット軟化点(JISK7206)
が100℃以上のものであり、柔軟性、透明性及び耐熱
性のバランスの点から好適である。A particularly preferred polypropylene-based crystalline polymer has a flexural modulus (JISK7203) of 9,000 k.
Vicat softening point below g / cm 2 (JISK7206)
Is 100 ° C. or higher, which is preferable from the viewpoint of the balance of flexibility, transparency and heat resistance.
【0013】そしてポリプロピレン系結晶性ポリマーは
成形性、成形物の力学的性質などを考慮すると、温度2
30℃、荷重2,160gにおけるMFR(メルトフロ
ーレイト)が0.3〜20より好ましくは0.5〜10
であるのがよい。The polypropylene-based crystalline polymer has a temperature of 2 in consideration of moldability and mechanical properties of the molded product.
MFR (melt flow rate) at 30 ° C. and a load of 2,160 g is preferably 0.3 to 20, more preferably 0.5 to 10
It should be
【0014】次に、(B)の一部を構成するポリマーの
うちポリプロピレン系アモルファスポリマー(以下、A
PPと称す)は非晶性のアタクチックポリプロピレン又
はこれを主成分とするポリマーであり、(A)で述べた
ポリプロピレン系結晶性ポリマーの製造工程で副生する
他、ラジカル重合等で製造され得る。Next, among the polymers constituting a part of (B), a polypropylene type amorphous polymer (hereinafter referred to as A
(Referred to as PP) is an amorphous atactic polypropylene or a polymer containing the same as a main component, which is produced as a byproduct in the production process of the polypropylene-based crystalline polymer described in (A), and can be produced by radical polymerization or the like. .
【0015】コポリマーの場合は(A)におけると同様
のコモノマーが用いられる。本発明で用いられるAPP
の性質としては190℃における溶融粘度が300〜1
00,000CPS、より好ましくは500〜80,0
00CPSであり、環球法で測定した軟化点が100〜
160℃、より好ましくは110〜150℃であること
がよい。In the case of copolymers, the same comonomers as in (A) are used. APP used in the present invention
As a property of, the melt viscosity at 190 ° C. is 300 to 1
0,000 CPS, more preferably 500-80,0
00 CPS, and the softening point measured by the ring and ball method is 100 to
The temperature is preferably 160 ° C, more preferably 110 to 150 ° C.
【0016】また、(B)の一部を構成するポリマーの
うちポリブテン系アモルファスポリマー(以下、APB
と称す)とはブテン−1及び/又はイソブチレンを主成
分とする無定形ポリブテン系ポリマーを意味し、通常公
知の方法で得られる。Among the polymers forming part of (B), polybutene-based amorphous polymers (hereinafter referred to as APB
Is referred to as) means an amorphous polybutene-based polymer containing butene-1 and / or isobutylene as a main component, and can be obtained by a generally known method.
【0017】これらのうちで特に好ましいのは、イソブ
チレンを主成分とし、ブテン−1を5〜30%程度コモ
ノマーとして含むポリマーである。Particularly preferred among these are polymers containing isobutylene as a main component and butene-1 as a comonomer in an amount of about 5 to 30%.
【0018】そして、成形性、基材の力学的性質などか
ら、APBは100℃における動粘度が2,000〜2
0,000cst、より好ましくは2,500〜10,
000cst程度であって、流動点が10〜50℃、よ
り好ましくは15〜45℃程度のものが適当である。From the viewpoint of moldability and mechanical properties of the base material, APB has a kinematic viscosity at 100 ° C. of 2,000 to 2.
10,000 cst, more preferably 2,500 to 10,
It is suitable that the pour point is about 000 cst and the pour point is 10 to 50 ° C, more preferably about 15 to 45 ° C.
【0019】(B)は上記APPもしくはAPBを含む
重合体組成物層である。即ち、APPやAPBの成形
性、シート形成能は実用性において問題があり、「他の
ポリマー」との重合体組成物の形で使う必要が生じる。
「他のポリマー」としては、前述したポリプロピレン系
結晶性ポリマーがAPPやAPBとの相溶性に優れるの
でよい。アイソタクチックポリブテン−1も結晶性でか
つAPPやAPBとの相溶性が良い点で使用可能であ
る。(B) is a polymer composition layer containing the above-mentioned APP or APB. That is, the moldability and sheet forming ability of APP and APB have problems in practical use, and it is necessary to use them in the form of a polymer composition with "other polymer".
The "other polymer" may be the above-mentioned polypropylene-based crystalline polymer because it has excellent compatibility with APP and APB. Isotactic polybutene-1 can also be used because it is crystalline and has good compatibility with APP and APB.
【0020】そして、APPもしくはAPBと「他のポ
リマー」(ポリプロピレン系結晶性ポリマーやアイソタ
クチックポリブテン−1)との重合体組成物は柔軟性、
成形性、シート形成能、力学的性質などの点からAPP
もしくはAPBが重合体組成物中の10〜80重量%、
より好ましくは15〜70重量%を占めるのがよい。The polymer composition of APP or APB and "other polymer" (polypropylene-based crystalline polymer or isotactic polybutene-1) is flexible,
APP in terms of formability, sheet forming ability, mechanical properties, etc.
Alternatively, APB is 10 to 80% by weight in the polymer composition,
More preferably, it should be 15 to 70% by weight.
【0021】次に、(C)を構成する低密度ポリエチレ
ン(以下、LDPEと称す)としてはいわゆる線状低密
度ポリエチレン(以下、LLDPEと称す)が好まし
い。高圧法LDPEに較べて、透明性、柔軟性、耐熱性
などのバランスにおいて優れるからである。Next, as the low density polyethylene (hereinafter referred to as LDPE) constituting (C), so-called linear low density polyethylene (hereinafter referred to as LLDPE) is preferable. This is because it has an excellent balance of transparency, flexibility, heat resistance, etc., as compared with the high-pressure LDPE.
【0022】LLDPEは周知の如く、エチレンに少量
の(好ましくは1〜10モル%、より好ましくは2〜8
モル%)プロピレン、ブテン−1、ペンテン−1、ヘキ
セン−1、ヘプテン−1、オクテン−1、デセン−1、
ドデセン−1、4−メチルベンテン−1などのα−オレ
フィン類を低圧法もしくは中圧法で共重合させて得られ
るが、透明性、柔軟性、耐熱性、成形性、力学的性質な
どを考慮すると密度が0.910〜0.930であるこ
が好ましく、温度190℃、荷重2,160gにおける
MFRが0.1〜10、より好ましくは0.5〜5.0
であるのがよい。As is well known, LLDPE is a small amount of ethylene (preferably 1 to 10 mol%, more preferably 2 to 8).
Mol%) propylene, butene-1, pentene-1, hexene-1, heptene-1, octene-1, decene-1,
It can be obtained by copolymerizing α-olefins such as dodecene-1,4-methylbenten-1 by a low pressure method or an intermediate pressure method, but considering transparency, flexibility, heat resistance, moldability, mechanical properties, etc. The density is preferably 0.910 to 0.930, the MFR at a temperature of 190 ° C. and a load of 2,160 g is 0.1 to 10, and more preferably 0.5 to 5.0.
It should be
【0023】冒頭に記載した如く、本発明の医療容器用
基材はポリプロピレン系結晶性ポリマーからなる層
(A)、APPもしくはAPBを重合体組成物として含
有する層(B)及びLDPEからなる層(C)によって
形成された多層体であり、(A)、(B)及び(C)が
それぞれ最外層、中間層及び最内層に位置している。か
ような形態とすることによって、良好な透明性、柔軟
性、耐熱性及び熱シール性が発現する。As described at the beginning, the medical container substrate of the present invention comprises a layer (A) made of a polypropylene crystalline polymer, a layer (B) containing APP or APB as a polymer composition, and a layer made of LDPE. It is a multilayer body formed by (C), and (A), (B) and (C) are located in the outermost layer, the intermediate layer and the innermost layer, respectively. With such a form, excellent transparency, flexibility, heat resistance and heat sealability are exhibited.
【0024】なお、本発明の医療容器用基材は必ずしも
3種3層型の多層体のみを意味しているわけではない。
つまり少なくとも上記要件を満たしていればよく、3種
4層型(例えば(A)/(B)/(A)/(C))、あ
るいは4種4層型(例えば(A)/(C1)/(B)/
(C2))など多様な形態をとることができる。The medical container base material of the present invention does not necessarily mean only a 3 type, 3 layer type multilayer body.
That is, it is sufficient that at least the above requirements are satisfied, a three-kind four-layer type (eg (A) / (B) / (A) / (C)) or a four-kind four-layer type (eg (A) / (C 1 ) / (B) /
(C 2 )) and various other forms.
【0025】また、場合によっては(A)と(B)との
間、(B)と(C)との間に接着用ポリマー(例えば無
水マレイン酸、酢酸ビニル、メタクリル酸メチルなどで
変性したポリエチレンやポリプロピレン)を用いてもよ
いことは言うまでもない。In some cases, between (A) and (B) and between (B) and (C), an adhesive polymer (eg, polyethylene modified with maleic anhydride, vinyl acetate, methyl methacrylate, etc.) is used. Needless to say, polypropylene or polypropylene) may be used.
【0026】また、上記多層体の厚さは、医療容器用基
材の用途に要求される柔軟性、透明性、耐熱性、強度、
ガスバリアー性などによって異なるが、一般にはシート
の場合、全体の肉厚は0.10〜1.0mm、より好ま
しくは0.1〜0.8mm位が適当であり、(A)、
(B)及び(C)の1層あたりの厚さはそれぞれ0.0
05〜0.15mm、0.08〜0.7mm及び0.0
05〜0.08mm、より好ましくは0.008〜0.
12mm、0.1〜0.4mm及び0.008〜0.0
5mm程度がよい。The thickness of the above-mentioned multi-layered body depends on the flexibility, transparency, heat resistance and strength required for the use of the substrate for medical containers.
Generally, in the case of a sheet, the total thickness is 0.10 to 1.0 mm, more preferably 0.1 to 0.8 mm, although it depends on the gas barrier property, etc. (A),
The thickness of each of (B) and (C) is 0.0
05-0.15 mm, 0.08-0.7 mm and 0.0
05-0.08 mm, more preferably 0.008-0.
12 mm, 0.1-0.4 mm and 0.008-0.0
About 5 mm is good.
【0027】なお、(A)の厚さの増大はシートの柔軟
性を損なう方向であり、また(C)の厚さの増大は透明
性が低下する方向であるので注意を要する。Note that an increase in the thickness of (A) tends to impair the flexibility of the sheet, and an increase in the thickness of (C) tends to decrease the transparency.
【0028】チューブの場合は全体の厚さが0.5〜
3.0mm、より好ましくは0.8〜2.0mm位が良
く、(A)及び(C)の1層あたりの厚さをシートの場
合と同程度にすればよい。(B)の1層あたりの厚さは
好ましくは0.1〜2.5mm、より好ましくは0.2
〜1.5mm程度がよい。なお、チューブの内径は1〜
20mm、更に好ましくは2〜15mm位が一般的であ
る。In the case of a tube, the total thickness is 0.5 to
The thickness is preferably 3.0 mm, more preferably 0.8 to 2.0 mm, and the thickness of each layer of (A) and (C) may be set to the same level as that of the sheet. The thickness per layer of (B) is preferably 0.1 to 2.5 mm, more preferably 0.2.
About 1.5 mm is preferable. The inner diameter of the tube is 1
It is generally 20 mm, and more preferably 2 to 15 mm.
【0029】本発明において医療容器とは血液、医薬液
等医療において扱われる液体を保存あるいは搬送する容
器やチューブを意味するが、かような製品は通常公知の
方法で得られる。In the present invention, the term "medical container" means a container or tube for storing or carrying a liquid such as blood or medical liquid used in medical treatment, and such a product can be obtained by a generally known method.
【0030】容器の場合は、(A)層、(B)層及び
(C)層(場合によっては他のポリマーをも用いること
がある)を多層用Tダイあるいは多層用サーキュラーダ
イを介して押出し(溶融温度は180〜250℃、より
好ましくは190〜230℃がよい)、得られたフラッ
ト状のシート、チューブ状のシート、パリソンなどにつ
いてサーモフォーミング、ブロー、延伸、裁断、融着
(熱シール)などの手法を適宜活用して所定の形状、形
態に加工すればよい。In the case of a container, the (A) layer, the (B) layer and the (C) layer (in some cases, other polymers may be used) are extruded through a multi-layer T die or a multi-layer circular die. (The melting temperature is preferably 180 to 250 ° C., more preferably 190 to 230 ° C.), the obtained flat sheet, tubular sheet, parison, etc. are subjected to thermoforming, blowing, stretching, cutting and fusing (heat sealing). ) Or the like may be used as appropriate to process into a predetermined shape and form.
【0031】熱シール性を考慮するとシートは無延伸状
態がよい。熱シールは温度170〜210℃、圧力5k
g/cm2 以下、時間2〜7秒で行われ得る(これに対
し、最内層(シール層)がポリプロピレン系結晶性ポリ
マーの場合は温度210〜250℃位の条件が必要とな
る他、仕上がり状態での不良が発生しやすい)。Considering the heat sealability, the sheet is preferably in a non-stretched state. Heat seal is 170-210 ℃, pressure is 5k
g / cm 2 or less, and the time may be 2 to 7 seconds. (In contrast, when the innermost layer (sealing layer) is a polypropylene-based crystalline polymer, a temperature of 210 to 250 ° C. or so is required. Defects are likely to occur in the state).
【0032】本発明の趣旨を損なわない範囲で、スチレ
ン系エラストマーやオレフィン系エラストマーを
(A)、(B)、(C)いずれかの層に添加すること、
シート間のブロッキングを防ぐために容器の内面や外面
を粗面化したりすることもあり得る。 チューブの製造
も同様に行われる。Addition of a styrene-based elastomer or an olefin-based elastomer to any of the layers (A), (B) and (C) within a range not impairing the gist of the present invention,
In order to prevent blocking between the sheets, the inner surface or outer surface of the container may be roughened. The tube is manufactured in the same manner.
【0033】本発明の基材は血液成分容器として、また
生理食塩水、電解質液、デキストラン製剤、マンニトー
ル製剤、糖類製剤、アミノ酸製剤、脂肪乳剤などの容器
として特に有用である。The base material of the present invention is particularly useful as a container for blood components and as a container for physiological saline, electrolyte solution, dextran preparation, mannitol preparation, saccharide preparation, amino acid preparation, fat emulsion and the like.
【0034】[0034]
【実施例】以下実施例によって本発明をさらに具体的に
説明するが、本発明はこれらに何ら限定されるものでは
ない。The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto.
【0035】(実施例1〜4、比較例1) (1)ポリマー原料およびシートについて 原料ポリマー:使用した原料ポリマーを表1に示す。(Examples 1 to 4, Comparative Example 1) (1) Polymer Raw Material and Sheet Raw Material Polymer: The raw material polymers used are shown in Table 1.
【0036】(B)層を形成する重合体組成物の調
製:ポリプロピレン系結晶性ポリマー及びAPP(もし
くはAPB)を原料とし、45mmφの二軸溶融混練押
出機を用いて、所定の割合で190〜200℃の温度範
囲で混練して押出されたストランドを水冷・カッティン
グ・乾燥して表1に示すペレット状重合体組成物を得
た。Preparation of polymer composition for forming layer (B): Using polypropylene-based crystalline polymer and APP (or APB) as raw materials, a biaxial melt-kneading extruder having a diameter of 45 mm and a predetermined ratio of 190 to 190. The extruded strands kneaded and kneaded in the temperature range of 200 ° C. were water-cooled, cut and dried to obtain pelletized polymer compositions shown in Table 1.
【0037】シートの作製:多層用のTダイから21
0〜220℃で3層シートを押出し、20℃に保たれた
キャスティングローラーで冷却後、トリミングして厚さ
0.36mm、幅200mmのシートを5m/分の速度
で捲き取った。多層シートの構成を表2に示す。Sheet preparation: 21 from multi-layer T-die
A three-layer sheet was extruded at 0 to 220 ° C., cooled by a casting roller kept at 20 ° C., trimmed, and a sheet having a thickness of 0.36 mm and a width of 200 mm was wound at a speed of 5 m / min. Table 2 shows the structure of the multilayer sheet.
【0038】(2)シートの評価方法: 多層シートの柔軟性の評価:(1)−で得られたシ
ートをダンベル状に裁断し、JISK7113に準じて
引張弾性率を測定し、柔軟性の尺度とした。(2) Evaluation method of sheet: Evaluation of flexibility of multilayer sheet: The sheet obtained in (1) -is cut into a dumbbell shape, and the tensile elastic modulus is measured according to JIS K7113 to obtain a measure of flexibility. And
【0039】多層シートの透明性の評価:(1)−
で得られたシートを150mm×250mmの大きさに
裁断し、これを(C)層がシール層となるように熱シー
ルして(シール条件については(2)−に記載)バッ
グを作製し、生理食塩水600mlを入れて密封した。
この薬液入り容器をレトルト型高圧蒸気滅菌機に入れ、
温度110℃、ゲージ圧1.8kg/cm2 、時間45
分の条件で処理した。室温まで冷却し、48時間放置
後、シートを切り取って波長450nmにおける水中透
過率を島津ダブルビーム型自記分光光度計UV−300
にて測定し、透明性の尺度とした。Evaluation of Transparency of Multilayer Sheet: (1)-
The sheet obtained in (1) was cut into a size of 150 mm × 250 mm, and heat-sealed so that the layer (C) became a sealing layer (for the sealing conditions, described in (2)-) to prepare a bag, 600 ml of physiological saline was added and sealed.
Put this chemical solution container in a retort type high pressure steam sterilizer,
Temperature 110 ° C, gauge pressure 1.8 kg / cm 2 , time 45
It was processed under the condition of minutes. After cooling to room temperature and leaving it for 48 hours, the sheet was cut out and the transmittance in water at a wavelength of 450 nm was measured by Shimadzu double beam type self-recording spectrophotometer UV-300.
Was used as a measure of transparency.
【0040】多層シートの熱シール性の評価:(1)
−で得られたシートを(C)層がシール層となるよう
に2枚合わせ、10mm幅×20mm長のシール寸法
で、圧力2kg/cm2 、時間5秒の条件で温度を17
0〜230℃の範囲で熱シールした。そして熱シール後
のサンプルについて引張試験機を用いて180℃剥離強
度を測定し、2kg/cmの強度が確保され、かつ「バ
リ」(肉溜りまたはハミダシ)の発生の少ない時の温度
を「適正シール温度」と判定した。((2)−の容器
はこの適正シール温度の範囲で作製した)。Evaluation of heat sealability of multilayer sheet: (1)
Two sheets obtained in step (-) were combined so that the layer (C) became a sealing layer, and the sealing dimensions were 10 mm width × 20 mm length, the pressure was 2 kg / cm 2 , and the temperature was 17 seconds.
Heat sealing was performed in the range of 0 to 230 ° C. Then, the heat-sealed sample was measured for peeling strength at 180 ° C using a tensile tester to secure a strength of 2 kg / cm, and the temperature when "burr" (flesh pool or humpback) was small Seal temperature ". (The container of (2)-was manufactured within this proper sealing temperature range).
【0041】重金属及び溶出物試験:日本薬局方一般
試験法「輸液用プラスチック容器試験法」に準じ、
(1)−で得られたシートについて試験を行った。Heavy metal and eluate test: According to the Japanese Pharmacopoeia general test method “Plastic container test method for infusion”,
A test was conducted on the sheet obtained in (1)-.
【0042】[0042]
【表1】 [Table 1]
【0043】(2)実験結果(表2参照) シートの押出成形は順調に行われ、いずれの組成にお
いても、異物、発泡、ブロッキングなどは観察されず、
均一性に富むシートが得られた。(2) Experimental results (see Table 2) Extrusion molding of the sheet was performed smoothly, and no foreign matter, foaming, blocking, etc. were observed in any composition,
A highly uniform sheet was obtained.
【0044】いずれの組成においても重金属及び溶出
物試験の結果は日本薬局方に適合することが確認され
た。It was confirmed that the results of the heavy metal and eluate tests were compatible with the Japanese Pharmacopoeia in any of the compositions.
【0045】表2にシート組成と柔軟性、透明性及び
熱シール性との関係を示すように、結晶性ポリプロピレ
ン系ポリマーを最外層((A)層)、アモルファスポリ
オレフィン含有重合体組成物を中間層((B)層)、低
密度ポリエチレンを最内層((C)層)とするシートの
性能はいずれも良好であった。As shown in Table 2 which shows the relationship between the sheet composition and the flexibility, transparency and heat sealability, the crystalline polypropylene polymer is the outermost layer ((A) layer) and the amorphous polyolefin-containing polymer composition is the intermediate layer. The performance of the sheet including the layer ((B) layer) and the low density polyethylene as the innermost layer ((C) layer) was good.
【0046】これに対し、最内層を結晶性ポリプロピレ
ン系ポリマーとすると、シール温度を高温にせざるを得
ないため柔軟な(B)層がシール部からはみ出してしま
い、良好な状態で熱シールできなかった。On the other hand, when the innermost layer is made of a crystalline polypropylene polymer, the sealing temperature has to be raised to a high temperature, so that the flexible (B) layer protrudes from the sealing portion and heat sealing cannot be performed in a good state. It was
【0047】[0047]
【表2】 [Table 2]
【0048】[0048]
【発明の効果】以上記載した如く、本発明の医療容器用
基材は結晶性ポリプロピレン系ポリマーの耐熱性、アモ
ルファスポリオレフィンの柔軟性及び低密度ポリエチレ
ンの良好な熱シール性を巧みに利用して生じたものであ
り、透明性、柔軟性、耐熱性及び製袋性に優れ、成形性
も良好であるのでその工業的価値は高いものがある。As described above, the medical container substrate of the present invention is produced by skillfully utilizing the heat resistance of crystalline polypropylene polymer, the flexibility of amorphous polyolefin and the good heat sealability of low density polyethylene. Since it is excellent in transparency, flexibility, heat resistance and bag-forming property and has good moldability, it has a high industrial value.
【0049】[0049]
───────────────────────────────────────────────────── フロントページの続き (72)発明者 落合 庄司 静岡県富士宮市三園平818番地 テルモ株 式会社内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Shoji Ochiai 818 Sanendaira, Fujinomiya-shi, Shizuoka Terumo Co., Ltd.
Claims (1)
する結晶性コポリマーからなる層(A)、ポリプロピレ
ン系もしくはポリブテン系アモルファスポリマーを重合
体組成物として含有する層(B)及び低密度ポリエチレ
ンからなる層(C)によって形成された多層体であっ
て、(A)、(B)及び(C)がそれぞれ最外層、中間
層及び最内層に存在することを特徴とする医療容器用基
材。1. A layer (A) made of crystalline polypropylene or a crystalline copolymer containing it as a main component, a layer (B) containing a polypropylene-based or polybutene-based amorphous polymer as a polymer composition, and low-density polyethylene. A multilayer body formed by layer (C), wherein (A), (B) and (C) are present in the outermost layer, the intermediate layer and the innermost layer, respectively.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5279461A JPH07164604A (en) | 1993-11-09 | 1993-11-09 | Base material for medicare container |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5279461A JPH07164604A (en) | 1993-11-09 | 1993-11-09 | Base material for medicare container |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH07164604A true JPH07164604A (en) | 1995-06-27 |
Family
ID=17611397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5279461A Pending JPH07164604A (en) | 1993-11-09 | 1993-11-09 | Base material for medicare container |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH07164604A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002052668A (en) * | 2000-08-07 | 2002-02-19 | Japan Polyolefins Co Ltd | Pouch |
| WO2009066752A1 (en) * | 2007-11-22 | 2009-05-28 | Mitsubishi Tanabe Pharma Corporation | Plastic container having cyclic polyolefin layer |
| JP2010081971A (en) * | 2008-09-29 | 2010-04-15 | Terumo Corp | Premix drug product of edaravone |
-
1993
- 1993-11-09 JP JP5279461A patent/JPH07164604A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002052668A (en) * | 2000-08-07 | 2002-02-19 | Japan Polyolefins Co Ltd | Pouch |
| WO2009066752A1 (en) * | 2007-11-22 | 2009-05-28 | Mitsubishi Tanabe Pharma Corporation | Plastic container having cyclic polyolefin layer |
| JPWO2009066752A1 (en) * | 2007-11-22 | 2011-04-07 | 田辺三菱製薬株式会社 | Plastic container containing a cyclic polyolefin layer |
| US9956203B2 (en) | 2007-11-22 | 2018-05-01 | Mitsubishi Tanabe Pharma Corporation | Plastic container comprising cyclic polyolefin layer |
| JP2010081971A (en) * | 2008-09-29 | 2010-04-15 | Terumo Corp | Premix drug product of edaravone |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4599276A (en) | Heat-sterilizable laminate films | |
| JP4879435B2 (en) | Moisture barrier structures based on multilayer polymers for medical grade products | |
| NZ276958A (en) | Multiple-layered polymer comprising a skin layer and a layer comprising propylene, a non-propylene, a r-f susceptible polymer and a compatibilizing polymer | |
| JPH08275985A (en) | Multi-layer film to package and administer medical solution | |
| HUP0203535A2 (en) | Autoclavable pvc-free multilayer film to be especially used for packing liquid, medicinal products, method for producing the same and the use thereof | |
| CA2484122C (en) | Multilayered polymer based thin film structure for medical grade products | |
| JP4393772B2 (en) | Medical container | |
| JP3549643B2 (en) | Medical substrate | |
| JPH07164604A (en) | Base material for medicare container | |
| US7566485B2 (en) | Medical container | |
| JP3054426B2 (en) | Medical bag | |
| JPH07125158A (en) | Base material for medical vessel | |
| JPH07124244A (en) | Base material for medical vessel | |
| JPH06169974A (en) | Base material for polyolefin medical care container | |
| JPH06171040A (en) | Polyolefin-based base material for medical container | |
| JPH07125159A (en) | Base material for medical vessel | |
| JP3625497B2 (en) | Medical container base material | |
| JP3973703B2 (en) | Medical multi-chamber container | |
| KR101273049B1 (en) | Polyolefin resin composition and multi-layer film including it | |
| JPH0999035A (en) | Vessel for medical treatment | |
| JPH06169972A (en) | Base material for polyolefin medical care container | |
| JPH06209981A (en) | Basic member for medical container | |
| JP3243084B2 (en) | Base material for medical containers | |
| JP3244349B2 (en) | Base material for medical containers | |
| KR100653407B1 (en) | Potato Tube for Non-Skiny Sap Bag |